MRONJ risk reduction pathway - 360 degree survey-Reference-Cited by-同舟云学术

MRONJ risk reduction pathway - 360 degree survey

Published:2017-03 Issue:5 Volume:222 Page:386-390
ISSN:0007-0610
Container-title:British Dental Journal
language:en
Short-container-title:Br Dent J

Author:

Muthukrishnan A.,Al-Ismail S.,Bertelli G.,Browne P.

Publisher

Springer Science and Business Media LLC

Subject

General Dentistry

Link

http://www.nature.com/articles/sj.bdj.2017.225.pdf

Reference28 articles.

1. Marx R E . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115–1117.

2. Hellstein J W, Adler R A, Edwards B et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2011; 142: 1243–1251.

3. Scottish Dental Clinical Effectiveness Programme. Oral Health Management of Patients Prescribed Bisphosphonates. Dundee: NHS Education for Scotland 2011.

4. Ruggiero S L, Dodson T B, Fantasia J et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the Jaw 2014 update. J Oral Maxillofac Surg 2014; 72: 1938–1956.

5. Ibrahim T, Barbanti F, Giorgio-Marrano G et al. Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates a retrospective study. Oncologist 2008; 13: 330–336.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities;Supportive Care in Cancer;2021-09-27

2. The Evaluation of Dentist’s Awareness and Knowledge in Turkey Regarding Bisphosphonates;Medical Records;2021-03-17

3. Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?;COMMUNITY DENT HLTH;2019

4. Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer;BMJ Case Reports;2019-02

5. The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention;BioMed Research International;2018-09-16